Tuesday, Mar 28, 2023
×
Outlook.com
×

Pfizer

Pfizer Buys Seagen For $43 Billion, Boosts Access To Cancer Drugs

The company, which changed its name from Seattle Genetics in 2020, saw total revenue grow about 25% last year to nearly  $2 billion

14 March 2023

Pfizer CEO Alberta Bourla

Pfizer CEO’s Davos Appearance Spark Conspiracies And Fake News – Here’s Why 

The annual World Economic Forum meeting in Davos has generally been a breeding ground for conspiracy theories and hyperbole on the internet

20 January 2023

Dr Reddy’s Acquires Trademark Rights Of Breast Cancer Drug Primcyv From Pfizer To Use In India

Dr Reddy’s Acquires Trademark Rights Of Breast Cancer Drug Primcyv From Pfizer To Use In India

Since May 2022, Dr. Reddy’s has been marketing the drug in collaboration with Pfizer Products India under the brandname Primcyv in India

13 January 2023

Covid-19 vaccine booster shots

Covishield Administered In India ‘Worse’ Due To Adverse Health Impact: Expert

Eminent British-Indian Cardiologist Dr Aseem Malhotra said there have already been international calls to suspend mRNA vaccines like those manufactured by Pfizer and Moderna because of the serious adverse effects especially...

07 February 2023

World Economic Forum

Coalition Sets 100-Day Goal For Faster, Equitable Pandemic Response

They also discussed how to overcome political obstacles to ensure vaccines are made more readily available to all

20 January 2023

China Covid-19 Surge

Pfizer's Paxlovid Not Included In China's National Insurance

Chinese healthcare authorities declined to include Pfizer's Covid-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too...

10 January 2023

Pfizer

Drugmaker Pfizer Starts Low With 2023 Earnings Forecast

Pfizer expects sales of both the vaccine Comirnaty and the treatment Paxlovid to tumble next year before starting to rebound

31 January 2023

Advertisement

Representational image

USA: Florida's Top Health Official Advises Against Covid mRNA Vaccines, Cites High Risk Of Heart Side Effects

An analysis by Florida government found an 84% increase in heart-related deaths among males aged 18-39 within 28 days following Covid-19 mRNA vaccination.

09 October 2022

Advertisement
26 August 2022
Moderna Sues Pfizer Over Patents Behind Covid-19 Vaccine

Moderna Sues Pfizer Over Patents Behind Covid-19 Vaccine

Covid-19 vaccine manufacturer Moderna is suing competitors Pfizer and BioNTech for allegedly copying its technology in making their vaccine.


22 August 2022
Pfizer Seeks Approval Of Updated Covid-19 Vaccine Booster For Fall

Pfizer Seeks Approval Of Updated Covid-19 Vaccine Booster For Fall

Drug manufacturer Pfizer has sought the approval of its combination Covid-19 vaccine that offers protection against the recent omicron variants.


29 June 2022
Gennova Biopharmaceuticals Is Ready To Roll Out 70 Lakh Doses Of Its Gemcovac-19 vaccine

Gennova Biopharmaceuticals Is Ready To Roll Out 70 Lakh Doses Of Its Gemcovac-19 vaccine

Gennova Biopharmaceuticals is awaiting approval of its Gemcovac-19 vaccine for restricted emergency use in adults.


23 May 2022
Pandemic Creates New Billionaire Every 30 hours: Oxfam At Davos

Pandemic Creates New Billionaire Every 30 hours: Oxfam At Davos

Oxfam Group's new report released in Davos that with the cost of essential goods rising, billionaires in the food and energy sectors are increasing their...


03 May 2022
Pfizer Tops Q1 Expectations, Revises 2022 Forecast

Pfizer Tops Q1 Expectations, Revises 2022 Forecast

Pfizer posted adjusted earnings of $1.62 per share in the first quarter, on $25.66 billion in revenue.


Advertisement

06 April 2022
Fourth Vaccine Dose Protects Elderly From COVID-19 But Protection Wanes Quickly: Study

Fourth Vaccine Dose Protects Elderly From COVID-19 But Protection Wanes Quickly: Study

The number of cases of severe COVID-19 per 100,000 person-days was 1.5 in the aggregated four-dose groups, 3.9 in the three-dose group, and 4.2 in the internal...


17 March 2022
More Than 30 Companies To Start Making Pfizer's COVID Pill

More Than 30 Companies To Start Making Pfizer's COVID Pill

Gore estimated that some of the generic companies might be ready to submit their drugs for regulatory approval later this year, with some supplies available in...


24 February 2022
CDC: Some People Should Wait Longer For 2nd COVID Shot

CDC: Some People Should Wait Longer For 2nd COVID Shot

CDC officials said that they were reacting to research showing that the longer interval can provide more enduring protection against the coronavirus.


23 February 2022
South Korea Approves Pfizer's COVID Vaccine For Ages 5-11

South Korea Approves Pfizer's COVID Vaccine For Ages 5-11

The Pfizer shot is already used for children aged 5 to 11 in more than 60 countries, including the United States and in the European Union.


07 February 2022
Pfizer India Appoints Pradip Shah As Chairman

Pfizer India Appoints Pradip Shah As Chairman

Pradip Shah is the ex-managing director and a founding member of CRISIL. Prior to founding CRISIL, he assisted in founding HDFC in 1977.  


09 January 2022
Do Pfizer’s Trial Results Justify Covid-19 Jabs For Kids?

Do Pfizer’s Trial Results Justify Covid-19 Jabs For Kids?

Did Pfizer’s trial in kids detect a Covid-19 problem to claim a solution? What about the long-term effects of vaccines?


Advertisement

17 December 2021
Japan PM, Pfizer CEO Hold Call To Expedite Covid-19 Booster Dose Supply

Japan PM, Pfizer CEO Hold Call To Expedite Covid-19 Booster Dose Supply

According to Chief Cabinet Secretary Hirokazu Matsuno, Japan has signed deals with US pharmaceutical giants Pfizer and Moderna for a combined 170 million doses...


17 December 2021
Covid-19 Vaccines: US CDC Panel Recommends Pfizer, Moderna Over J&J Shot

Covid-19 Vaccines: US CDC Panel Recommends Pfizer, Moderna Over J&J Shot

Observing that there have been nine confirmed deaths in the US after Johnson and Johnson Covid-19 vaccine shots, the US' Center for Disease Control and...


16 December 2021
Omicron Variant: South Africa Develops Indigenous Covid-19 Vaccine

Omicron Variant: South Africa Develops Indigenous Covid-19 Vaccine

South Africa is grappling with the fourth wave of the Covid-19 driven by the Omicron variant. The country is pushing for more vaccinations — and for its own...


15 December 2021
Omicron Covid-19 Variant Expected To Be Dominant By Mid January: EU Official

Omicron Covid-19 Variant Expected To Be Dominant By Mid January: EU Official

Omicron Covid-19 Variant European Commission President Ursula von der Leyen said that the bloc is well prepared to fight the variant with 66.6% of the European...


14 December 2021
Covid-19: Pfizer Vaccine Not Effective Against Omicron Like Delta, Finds South Africa Analysis

Covid-19: Pfizer Vaccine Not Effective Against Omicron Like Delta, Finds South Africa Analysis

Covid-19 Omicron variant was first detected in South Africa. The large-scale analysis of Pfizer vaccine effectiveness seems to support early indications that...


07 December 2021
EU Drug Regulator Backs Covid-19 Vaccine Mixture

EU Drug Regulator Backs Covid-19 Vaccine Mixture

EU (European Union) drug regulator said in a statement that using different types of vaccines together, known as heterologous vaccination, can provide...


Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement